Analyst Reco. Reviva Pharmaceuticals Holdings, Inc.

Stocks

Delayed OTC Markets Other stock markets 15:48:08 11/06/2026 BST			5-day change	1st Jan Change
0.7100 ^USD	-5.09%		+15.98%	-87.28%

05-20	Certain Common Warrants of Reviva Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 20-MAY-2026.	CI
05-20	Certain Stock Options of Reviva Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 20-MAY-2026.	CI

29/09/25	Chardan Initiates Reviva Pharmaceuticals Holdings at Buy With $2 Price Target	MT
23/09/24	EF Hutton Initiates Reviva Pharmaceuticals at Buy Rating With $15 Price Target	MT
11/06/24	HC Wainwright Adjusts Price Target on Reviva Pharmaceuticals Holdings to $14 From $20, Maintains Buy Rating	MT
31/10/23	HC Wainwright Raises Reviva Pharmaceuticals' Price Target to $20 From $10, Keeps Buy Rating	MT
20/09/23	Roth MKM Initiates Reviva Pharmaceuticals With Buy Rating, Price Target is $12	MT
08/06/23	Benchmark Initiates Reviva Pharmaceuticals at Speculative Buy With $17 Price Target	MT
03/05/23	Maxim Adjusts Price Target on Reviva Pharmaceuticals Holdings to $18 From $10, Maintains Buy Rating	MT
01/11/22	Alliance Global Starts Reviva Pharmaceuticals Holdings at Buy With $16 Price Target	MT
01/11/22	Maxim Group Adjusts Price Target on Reviva Pharmaceuticals Holdings to $10 From $3, Maintains Buy Rating	MT
28/07/22	Maxim Lowers Price Target for Reviva Pharmaceuticals Holdings to $3 From $5, Maintains Buy Rating	MT
24/01/22	HC Wainwright Starts Reviva Pharmaceuticals Holdings at Buy With $10 Price Target	MT
26/07/21	REVIVA PHARMACEUTICALS : Maxim Group Initiates Reviva Pharmaceuticals at Buy Rating With $10 Price Target	MT